Avalo Therapeutics Ownership | Who Owns Avalo Therapeutics?
Avalo Therapeutics Ownership Summary
Avalo Therapeutics is owned by 61.50% institutional investors, and 38.50% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.58% of its assets in Avalo Therapeutics shares.
AVTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Avalo Therapeutics | 61.50% | - | 38.50% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | 42 | -34.38% | 69,378,775 | -10.69% | 61 | 1.30% | 14 | -30.00% | 19 | -32.14% |
| Mar 31, 2022 | 64 | -12.33% | 77,679,178 | -2.87% | 68 | 1.09% | 20 | -52.38% | 28 | 86.67% |
| Dec 31, 2021 | 73 | -3.95% | 79,978,021 | -0.58% | 79 | 1.24% | 42 | -42.47% | 15 | - |
| Sep 30, 2021 | 76 | - | 80,445,353 | - | 80 | - | 73 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 165.80K | 1.58% | 155.43K |
| Extended Equity Market Fund K | 19.47K | 0.19% | 19.47K |
| NT Ext Equity Mkt Idx Fd - NL | 11.56K | 0.11% | 11.55K |
| NT Ext Equity Mkt Idx Fd - L | 10.61K | 0.10% | 8.20K |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 9.17K | 0.09% | 9.15K |
| Fidelity Extended Market Index | 4.99K | 0.05% | -33.00 |
| Northern Trust Extended Eq Market Idx | 2.41K | 0.02% | - |
| Extended Equity Market Fund M | 2.53K | 0.02% | 2.53K |
| NT Ext Eq Mkt Indx Fd DC Lend T4 | 2.53K | 0.02% | 2.53K |
| NT Ext Eq Mkt Indx Fd DC Lend T3 | 2.53K | 0.02% | 2.53K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 13, 2024 | Almenoff June Sherie | - | Buy | $6.50K |
| Nov 12, 2024 | Almenoff June Sherie | - | Buy | $6.25K |
| Jun 26, 2023 | ARMISTICE CAPITAL, LLC | - | Sell | $1.68M |
| Jun 27, 2023 | ARMISTICE CAPITAL, LLC | - | Sell | $486.89K |
| Jun 26, 2023 | Caissa Capital Management ltd. | - | Sell | $113.03K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 2 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
AVTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools